FDA Clearance Tracker · K220397
ANSiStim-PP
Last checked: Nov 19, 2026Latest source record: May 12, 2022 (this decision)Source: openFDAMethods & limitations
Decided
May 12, 2022
Substantially Equivalent
Time to decision
90 days
Received Feb 11, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K220397
- Device name
- ANSiStim-PP
- Applicant
- Dyansys, Inc.
- Applicant location
- San Mateo, CA
- Received
- Feb 11, 2022
- Decided
- May 12, 2022
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.5890
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NHI. The earliest in FDA's data is K011702, decided Dec 21, 2001.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K220397
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Dyansys, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Primary Relief510(k)
K221425 · Decided Sep 13, 2022 · 120 days after receipt
Device type: Stimulator, Nerve, Electrical, Percutaneous (Pens), For Pain Relief (NHI) · Neurology & Neurosurgery
- Drug Relief v1510(k)
K221231 · Decided Jun 6, 2022 · 38 days after receipt
Device type: Percutaneous Nerve Stimulator For Opioid Withdrawal (PZR) · Neurology & Neurosurgery
- Primary Relief510(k)
K213188 · Decided Jan 31, 2022 · 124 days after receipt
Device type: Stimulator, Nerve, Electrical, Percutaneous (Pens), For Pain Relief (NHI) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.